668 related articles for article (PubMed ID: 21415703)
1. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
3. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
Guillou L; Benhattar J; Gengler C; Gallagher G; Ranchère-Vince D; Collin F; Terrier P; Terrier-Lacombe MJ; Leroux A; Marquès B; Aubain Somerhausen Nde S; Keslair F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2007 Sep; 31(9):1387-402. PubMed ID: 17721195
[TBL] [Abstract][Full Text] [Related]
4. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma.
Arbajian E; Puls F; Magnusson L; Thway K; Fisher C; Sumathi VP; Tayebwa J; Nord KH; Kindblom LG; Mertens F
Am J Surg Pathol; 2014 Jun; 38(6):801-8. PubMed ID: 24441665
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
Matsuyama A; Hisaoka M; Shimajiri S; Hayashi T; Imamura T; Ishida T; Fukunaga M; Fukuhara T; Minato H; Nakajima T; Yonezawa S; Kuroda M; Yamasaki F; Toyoshima S; Hashimoto H
Am J Surg Pathol; 2006 Sep; 30(9):1077-84. PubMed ID: 16931951
[TBL] [Abstract][Full Text] [Related]
6. The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.
Panagopoulos I; Storlazzi CT; Fletcher CD; Fletcher JA; Nascimento A; Domanski HA; Wejde J; Brosjö O; Rydholm A; Isaksson M; Mandahl N; Mertens F
Genes Chromosomes Cancer; 2004 Jul; 40(3):218-28. PubMed ID: 15139001
[TBL] [Abstract][Full Text] [Related]
7. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features.
Mohamed M; Fisher C; Thway K
Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941
[TBL] [Abstract][Full Text] [Related]
8. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma.
Thway K; Fisher C; Debiec-Rychter M; Calonje E
Hum Pathol; 2009 Nov; 40(11):1586-90. PubMed ID: 19540561
[TBL] [Abstract][Full Text] [Related]
9. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool.
Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR
Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449
[TBL] [Abstract][Full Text] [Related]
10. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
Bahrami A; Folpe AL
Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
[TBL] [Abstract][Full Text] [Related]
11. Low-grade fibromyxoid sarcoma of the small intestine: report of 4 cases with molecular cytogenetic confirmation.
Laurini JA; Zhang L; Goldblum JR; Montgomery E; Folpe AL
Am J Surg Pathol; 2011 Jul; 35(7):1069-73. PubMed ID: 21677541
[TBL] [Abstract][Full Text] [Related]
12. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases.
Rekhi B; Deshmukh M; Jambhekar NA
Ann Diagn Pathol; 2011 Oct; 15(5):303-11. PubMed ID: 21550274
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular low-grade fibromyxoid sarcoma: a case report.
Liao KS; Huang WT; Yang SF; Chien SH; Hsieh TJ; Chai CY; Wu CC
Kaohsiung J Med Sci; 2009 Aug; 25(8):448-54. PubMed ID: 19605340
[TBL] [Abstract][Full Text] [Related]
14. Hyalinizing spindle cell tumor with giant rosettes and low-grade fibromyxoid sarcoma: an immunohistochemical and ultrastructural comparative investigation.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2003; 27(5):349-55. PubMed ID: 14708726
[TBL] [Abstract][Full Text] [Related]
15. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
16. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features.
Oda Y; Takahira T; Kawaguchi K; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Histopathology; 2004 Jul; 45(1):29-38. PubMed ID: 15228441
[TBL] [Abstract][Full Text] [Related]
17. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
Thway K; Ng W; Benson C; Chapman J; Fisher C
Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
[TBL] [Abstract][Full Text] [Related]
18. Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features.
Meng GZ; Zhang HY; Bu H; Geng JG
Diagn Cytopathol; 2009 Feb; 37(2):96-102. PubMed ID: 19021197
[TBL] [Abstract][Full Text] [Related]
19. Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature.
Cowan ML; Thompson LD; Leon ME; Bishop JA
Head Neck Pathol; 2016 Jun; 10(2):161-6. PubMed ID: 26276044
[TBL] [Abstract][Full Text] [Related]
20. Low-grade fibromyxoid sarcoma with prominent giant rosettes and heterotopic ossification.
Hisaoka M; Matsuyama A; Aoki T; Sakamoto A; Yokoyama K
Pathol Res Pract; 2012 Sep; 208(9):557-60. PubMed ID: 22819758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
